Orgenesis Inc (NASDAQ:ORGS)
| 0.6498 Delayed Data As of Sep 28 |  0.00 / 0.00%Today’s Change | 0.38 Today|||52-Week Range 2.64 | -66.68% Year-to-Date |
Latest ORGS News | Press Releases
No recent news for Orgenesis Inc.
Today’s Trading
| Previous close | 0.65 |
| Today’s open | 0.65 |
| Day’s range | 0.65 - 0.65 |
| Volume | 1 |
| Average volume (3 months) | 74,825 |
| Market cap | $17.8M |
Data as of 12:13pm ET, 09/28/2023
Growth & Valuation
| Earnings growth (last year) | +20.22% |
| Earnings growth (this year) | +135.59% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +1.47% |
| P/E ratio | NM |
| Price/Sales | 1.36 |
| Price/Book | 0.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TARAProtara Therapeutics... | -0.03 | -1.79% |
| ZIVOZivo Bioscience Inc | +0.18 | +15.25% |
| AEZSAeterna Zentaris Inc | 0.00 | 0.00% |
| BCELAtreca Inc | -0.01 | -2.94% |
Data as of 3:59pm ET, 09/29/2023
Financials
| Next reporting date | November 10, 2023 |
| EPS forecast (this quarter) | $0.10 |
| Annual revenue (last year) | $36.0M |
| Annual profit (last year) | -$14.9M |
| Net profit margin | -41.33% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Germantown, Maryland |
Forecasts
